PerkinElmer to buy diagnostics firm Oxford Immunotec Global for $591m
The acquisition is expected to enable PerkinElmer to expand its portfolio of advanced infectious disease testing solutions
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jan 21
The acquisition is expected to enable PerkinElmer to expand its portfolio of advanced infectious disease testing solutions
08 Jan 21
Saliva-based tests rapidly expand access and testing options to combat COVID-19 in the UK
07 Jan 21
Approved by Swissmedic, the FORA Covid-19 Antigen Rapid Test is a diagnostic antigen test for the direct detection…
07 Jan 21
LifeKit Prevent is a non-invasive colorectal cancer screening test that detects the early warning signs of cancer, precancerous…
06 Jan 21
The automatic slide staining system from cancer diagnostic specialist Biocare Medical can process 36 slides at once
06 Jan 21
Biotheranostics provides PCR-based gene expression tests, which have been validated in large studies in areas of oncology
06 Jan 21
The FDA authorisation allows the easy administration of serology test in point-of-care settings, which delivers results in 15-20…
06 Jan 21
Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics
05 Jan 21
The new test designed by the University of Birmingham uses a proprietary method pending patent approval to amplify…
05 Jan 21
Somatex offers minimally invasive devices in the areas of tumour diagnostics, biopsy and interventional specialties